KEVIN FISHER to Precursor Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications KEVIN FISHER has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
0.101
-
Ponatinib use in two pediatric patients with relapsed Ph?+?ALL with ABL1 kinase domain mutations. Pediatr Hematol Oncol. 2019 11; 36(8):514-519.
Score: 0.101
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.